News Focus
News Focus
icon url

Skydive21

06/03/21 3:58 PM

#6046 RE: Dragon Lady #6041

Clinical trials to FDA standards are very expensive. If an IND is in the works then QNTA management is preparing to sell shares to raise money for the trials.
This is possibly the reason for change AS.